Join
Live feed
·
PRReleasevia Quantisnow
Becton Dickinson and Company logo

EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch

ByQuantisnow·Wall Street's wire, on your screen.
BDX· Becton Dickinson and Company
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BDX (Becton Dickinson and Company) and more on Quantisnow.